Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 09:39 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | TN | 40 beds | Grade C | EBITDA uplift $1.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 443035 | WILLIAMSON, TN | 40 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 40-bed community hospital in WILLIAMSON, TN with $16.0M in net patient revenue and a 7.3% operating margin. The hospital serves a payer mix of 56.7% Medicare, 0.0% Medicaid, and 43.3% commercial.

Thesis: Turnaround. Our ML models identify $1.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 7.3% to 14.6% (+736bps).

Net Revenue HCRIS$16.0M
Current EBITDA COMPUTED$1.2M
Operating Margin COMPUTED7.3%
Occupancy HCRIS73.0%
Revenue / Bed COMPUTED$400K
Net-to-Gross HCRIS60.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
67
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 7.3% places it above the state median. Among 67 size-comparable peers (20-80 beds), the median margin is -0.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-80), prioritizing same-state peers. 67 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)TN40$16.0M7.3%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
LECONTE MEDICAL CENTERTN60$126.3M6.4%
FRANKLIN WOODS COMMUNITY HOSPITN80$110.3M18.7%
CUMBERLAND MEDICAL CENTERTN72$84.3M-12.0%
HENRY COUNTY MEDICAL CENTERTN43$81.7M-13.0%
VANDERBILT TULLAHOMA-HARTON HOTN71$79.5M-8.2%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$336K+210bp18mo
Cost to Collect4.5%2.5%$320K+200bp12mo
Denial Rate Reduction12.0%6.5%$317K+198bp12mo
A/R Days Reduction5200.0%3800.0%$195K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$336K
Cost to Collect
$320K
Denial Rate Reduction
$317K
A/R Days Reduction
$195K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.2M
Current EBITDA$1.2M
+ RCM Uplift+$1.2M
Pro Forma EBITDA$2.3M
Current Margin7.3%
Pro Forma Margin14.6%
WC Released (1x)$614K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.8M$19.5M10.87x61.2%
Base (11x exit)10.0x11.0x$1.8M$22.0M12.28x65.1%
Bull Case9.0x11.0x$1.6M$26.5M16.42x75.0%
Bull (12x exit)9.0x12.0x$1.6M$29.3M18.20x78.7%
Bear Case11.0x10.0x$2.0M$13.0M6.59x45.8%
Bear (11x exit)11.0x11.0x$2.0M$14.9M7.58x49.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 56.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 67 hospitals with 20-80 beds
  • Same-state prioritization (n=68)
  • Comp margins: P25=-12.5% / P50=-0.4% / P75=9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.